David Dadiomov, PharmD, BCPP, is a clinical assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy. He received his PharmD from the University of Michigan College of Pharmacy. Dr. Dadiomov completed his PGY1 Pharmacy Residency at Michigan Medicine, and his PGY2 Psychiatric Pharmacy Residency at the University of California, San Diego, Health. He holds board certification in psychiatric pharmacy. Dadiomov serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. Dr. Dadiomov currently practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest if its kind in the United States. In this role he has worked to establish novel clinical pharmacy services for patients experiencing homelessness, incarcerated patients, and those with severe mental illness and addiction disorders.


As a board-certified clinical psychiatric pharmacist, Dr. Dadiomov works both in direct patient care and allied health settings, to treat high risk patients. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more.


Dr. Dadiomov has a passion for teaching practical patient care, with a particular focus on achieving outstanding clinical outcomes through innovative interventions. His teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. David’s expertise has been shared with experienced clinicians, graduate students and advanced level students. David is the recipient of multiple awards for clinical excellence, teaching and clinical innovation. He has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, scientific presentations and more.

Speaker Disclosures:

Financial: Dr. David Dadiomov has employment relationships with the University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, the University of Southern California Psychiatry and Behavioral Sciences Medical Residency, and the Los Angeles County Department of Health Services. He receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.

Non-financial: Dr. David Dadiomov is a member of the American Society of Addiction Medicine, the College of Psychiatric and Neurologic Pharmacists, the American College of Clinical Pharmacy, the American Association of Colleges of Pharmacy, and the American Society of Health-System Pharmacists. He is a reviewer for several publications, for a complete list contact PESI.com.